Company / PP&E per Share
Inhibrx Biosciences, Inc. PP&E per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.26
FY2025
5-year range
$0.13 / $0.54
FY2023-FY2025
Trend
+97.0%
vs FY2024
Sector context
#76 of 191
Health Care
What the data says
At $0.26, Inhibrx Biosciences, Inc.'s pp&e per share ranks #76 of 191 in the Health Care sector. Declined from $0.54 to $0.26 over the past 2 years.
Based on SEC 10-K filings.
0.26 in FY2025.
Declined from $0.54 to $0.26 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 191 in Health CareTop 40% of 191This company $0.26 Sector average $22.34
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 97.0% year-over-year.
- Ranks #76 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | +97.0% |
| FY2024 | $0.13 | -76.0% |
| FY2023 | $0.54 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026